Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Gelteq Limited's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Gelteq Limited (GELS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2024
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q4 2024
Revenue Growth Y/Y
-
Q4 2024
Net Margin
-4,057.89 %
Q4 2024

Key Findings: Gelteq Limited vs Its Competitors

  • TTM: Trailing 12-month revenue of 0M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+113.5% annualized vs trailing 12 months).
  • Peer revenue share: Gelteq Limited accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

GELS Sales vs. its Competitors, Q4 2024

Gelteq Limited generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/GELS/competitors
https://api.csimarket.com/api/v1/companies/GELS/relationships
https://api.csimarket.com/api/v1/companies/GELS/similar
Programmatic access for models, analytics, and integration workflows.

Gelteq Limited's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Gelteq Limited - - - -
High-Confidence Competitors (3) 0% 50% 50% 100%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2024

100%market share
  • Gelteq Limited100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Gelteq Limited and its 0 tracked competitors.

See Gelteq Limited's full market share breakdown »

GELS Stock Performance relative to its Competitors

GELS Competitors (weighted) Percent change over the selected range

Gelteq Limited's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 2)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Gelteq Limited - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (2) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Gelteq Limited's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

GELS Stock Performance relative to High-Confidence Competitors

GELS High-Confidence Competitors (equal-weighted, 3) Percent change over the selected range

Gelteq Limited's Comment on Competition and Industry Peers

The company focuses on markets with high margins and limited competition, including pet nutrients, nutraceuticals, human supplements, pharmaceutical, and over-the-counter (OTC) sectors. Its gel delivery system provides taste masking advantages distinct from competitors that blunt taste receptors. The oral drug delivery market is substantial and expanding, with relatively few innovations in delivery methods. Competitors in this space include Medifast Inc., Protalix BioTherapeutics Inc., AcelRx Pharmaceuticals Inc., and Poxel SA.

Gelteq Limited's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Virpax Pharmaceuticals Inc. Named by the company 85% 2022 to 2026 3
Hempfusion Wellness Inc. Named by the company 85% 2022 to 2026 3
Healthy Extracts Inc Named by the company 85% 2022 to 2026 3
Nutriband Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Gelteq Limited's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License